梅毒免疫測定診断薬の世界市場レポート 2025年

梅毒免疫測定診断薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.7％で454億2,000万米ドルに成長します。予測期間の成長は、ハイリスク人口の急増、パートナー通知プログラムに関する認知度の向上、有病率の上昇、梅毒免疫測定診断薬に対する認知度の向上、ヘルスケアに対する政府支出の急増に起因しています。予測期間における主な動向としては、革新的技術の採用、迅速なポイントオブケア検査の開発、家庭用検査キットの需要拡大、検査室検査法の進歩、診断検査技術の拡大などが挙げられます。

性感染症（STD）の有病率の増加は、今後数年間の梅毒免疫測定診断薬市場の成長を牽引すると予想されます。STD（性感染症）は、主に膣、肛門、オーラルセックスなどの性的接触によって感染します。STDの増加は、コンドーム使用の減少、抗生物質耐性、性教育の欠如、社会・行動パターンの変化、スティグマ、STD予防プログラムへの資金提供の減少、旅行の増加などの要因に起因しています。梅毒免疫測定診断薬は、梅毒感染を正確かつタイムリーに特定することで、適切な治療と予防措置を可能にし、STDの発見と管理において重要な役割を果たしています。例えば、2024年6月、英国を拠点とするテレンス・ヒギンズ・トラスト（Terrence Higgins Trust）は、英国保健安全保障局（UKHSA）のデータによると、2023年にイングランドで報告されたSTIは40万1,800件で、前年から5％増加したと報告しました。その結果、性病罹患率の増加が梅毒免疫測定診断薬の需要に拍車をかけています。

梅毒免疫測定診断薬市場の主要企業は、梅毒検出の効率と精度を高めるため、迅速梅毒検査を含む革新的ソリューションの開発を優先しています。梅毒迅速検査は、血液または体液中の梅毒抗体を数分以内に検出し、迅速な診断と早期治療を促進する、使いやすいポイント・オブ・ケアツールです。例えば、2023年2月、米国を拠点とする感染症のポイントオブケア診断を専門とするChem Bio Diagnostics Inc.は、DPP HIV-梅毒システムに関してFDAからCLIA免除を受けた。この二重迅速検査は、HIV1/2と梅毒の原因菌であるTreponema pallidumに対する抗体を同時に検出するように設計されています。わずか15分で治療が完了するこの検査は、診断精度と治療効果を高めることを目的としており、特に梅毒の母子トランスミッションを予防し、梅毒患者のHIV感染リスクを低減することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界梅毒免疫測定診断薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の梅毒免疫測定診断薬市場：成長率分析
• 世界の梅毒免疫測定診断薬市場の実績：規模と成長, 2019-2024
• 世界の梅毒免疫測定診断薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界梅毒免疫測定診断薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の梅毒免疫測定診断薬市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アナライザー
• 試薬
• キット
• その他の製品
• 世界の梅毒免疫測定診断薬市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学発光免疫測定（CLIA）
• 酵素免疫測定（ELISA）
• その他のテクノロジー
• 世界の梅毒免疫測定診断薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 男性
• 女性
• 世界の梅毒免疫測定診断薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 血液銀行
• 診断ラボ
• その他のエンドユーザー
• 世界の梅毒免疫測定診断薬市場、分析装置のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動分析装置
• 半自動分析装置
• 手動分析装置
• 世界の梅毒免疫測定診断薬市場、試薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酵素結合免疫吸着測定試薬
• 化学発光免疫測定試薬
• 迅速血漿レアギン試薬
• トレポネーマおよび非トレポネーマ試薬
• 世界の梅毒免疫測定診断薬市場キットの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ELISAキット
• 迅速診断検査キット
• CLIAキット
• ポイントオブケア検査キット
• 世界の梅毒免疫測定診断薬市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 管理および校正材料
• サンプル収集装置
• 補助テストアクセサリ

第7章 地域別・国別分析

• 世界の梅毒免疫測定診断薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の梅毒免疫測定診断薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 梅毒免疫測定診断薬市場：競合情勢
• 梅毒免疫測定診断薬市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• bioMerieux SA
• Bio-Rad Laboratories Inc.
• Meril Life Sciences Pvt. Ltd.
• Randox Laboratories Ltd.
• SEKISUI Diagnostics
• Bloodworks Northwest
• LetsGetChecked
• Everlywell Inc.
• ACON Laboratories Inc.
• Trinity Biotech
• Fujirebio
• CTK Biotech Inc.
• bioLytical Laboratories Inc.
• AdvaCare Pharma
• MyBioSource.com

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 梅毒免疫測定診断薬市場2029：新たな機会を提供する国
• 梅毒免疫測定診断薬市場2029：新たな機会を提供するセグメント
• 梅毒免疫測定診断薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Syphilis immunoassay diagnostics refer to laboratory tests designed to detect antibodies or antigens associated with the bacterium treponema pallidum, the causative agent of syphilis. These diagnostics utilize immunoassay techniques to detect specific immune responses present in the blood. The primary objective of syphilis immunoassay diagnostics is to accurately diagnose syphilis infections, facilitating prompt and effective treatment.

Key products in syphilis immunoassay diagnostics include analyzers, reagents, kits, and related items. Analyzers are devices employed in laboratories to analyze samples for the presence of syphilis. Various technologies utilized include chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), among others. These diagnostics cater to applications in both men and women and serve diverse end-users such as hospitals, blood banks, diagnostic laboratories, and others.

The syphilis immunoassay diagnostics market research report is one of a series of new reports from The Business Research Company that provides syphilis immunoassay diagnostics market statistics, including the syphilis immunoassay diagnostics industry global market size, regional shares, competitors with syphilis immunoassay diagnostics market share, detailed syphilis immunoassay diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the syphilis immunoassay diagnostics industry. These syphilis immunoassay diagnostics market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The syphilis immunoassay diagnostics market size has grown strongly in recent years. It will grow from $31.25 billion in 2024 to $33.76 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rise in socioeconomic factors such as STDs, increasing percentage of unidentified sex, growing incidences of fatal syphilis diseases, growing initiatives by the government, and rising emphasis on early detection of the diseases.

The syphilis immunoassay diagnostics market size is expected to see strong growth in the next few years. It will grow to $45.42 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rapid growth of high-risk population, increasing awareness about partner notification programs, rise in the prevalence, increase awareness of syphilis immunoassay diagnostics, and surge in government expenditure on healthcare. Major trends in the forecast period include adoption of innovative technologies, development of rapid point-of-care tests, growing demand for home test kits, advancements in laboratory testing methods, and expansion of the diagnostic laboratory techniques.

The increasing prevalence of sexually transmitted diseases (STDs) is expected to drive the growth of the syphilis immunoassay diagnostics market in the coming years. STDs, or sexually transmitted infections (STIs), are primarily spread through sexual contact, including vaginal, anal, and oral sex. The rise in STDs can be attributed to factors such as reduced condom use, antibiotic resistance, lack of sexual education, changes in social and behavioral patterns, stigma, reduced funding for STD prevention programs, and greater travel. Syphilis immunoassay diagnostics play a critical role in the detection and management of STDs by providing accurate and timely identification of syphilis infections, which enables appropriate treatment and preventive measures. For example, in June 2024, the UK-based Terrence Higgins Trust reported that data from the UK Health Security Agency (UKHSA) indicated 401,800 STIs were reported in England in 2023, a 5% increase from the previous year. As a result, the growing incidence of STDs is fueling the demand for syphilis immunoassay diagnostics.

Major companies in the syphilis immunoassay diagnostics market are prioritizing the development of innovative solutions, including rapid syphilis tests, to enhance the efficiency and accuracy of syphilis detection. Rapid syphilis tests are user-friendly, point-of-care tools that detect syphilis antibodies in blood or bodily fluids within minutes, facilitating prompt diagnosis and early treatment. For example, in February 2023, Chembio Diagnostics Inc., a US-based company specializing in point-of-care diagnostics for infectious diseases, received a CLIA waiver from the FDA for its DPP HIV-Syphilis System. This dual rapid test is designed to simultaneously detect antibodies to HIV 1/2 and Treponema pallidum, the bacterium that causes syphilis. Conducted in just 15 minutes, this test aims to enhance diagnostic accuracy and treatment efficacy, particularly in preventing mother-to-child transmission of syphilis and reducing the risk of HIV transmission among individuals with syphilis.

In April 2023, Biosynex SA, a France-based company specializing in syphilis immunoassay diagnostics, acquired Chembio Diagnostics, Inc. for $17.2 million. This strategic acquisition aims to bolster Biosynex's market footprint in North America by leveraging Chembio's established portfolio of FDA-approved products and expertise in rapid diagnostic tests. Chembio Diagnostics Inc., based in the United States, is renowned for its focus on point-of-care diagnostics for infectious diseases, including syphilis.

Major companies operating in the syphilis immunoassay diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Meril Life Sciences Pvt. Ltd., Randox Laboratories Ltd., SEKISUI Diagnostics, Bloodworks Northwest, LetsGetChecked, Everlywell Inc., ACON Laboratories Inc., Trinity Biotech, Fujirebio, CTK Biotech Inc., bioLytical Laboratories Inc., AdvaCare Pharma, MyBioSource.com, Gold Standard Diagnostics Frankfurt GmbH, Newmarket Biomedical Ltd, InTec PRODUCTS INC., NuGenerex Diagnostics LLC

North America was the largest region in the syphilis immunoassay diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the syphilis immunoassay diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the syphilis immunoassay diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The syphilis immunoassay diagnostics market consists of revenues earned by entities by providing services such as sample collection services, laboratory testing services, point-of-care testing services, and consultation and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The syphilis immunoassay diagnostics market also consists of sales of rapid plasma reagin (RPR) tests, fluorescent treponemal antibody absorption (FTA-ABS) tests, point-of-care (POC) tests, western blot assays, and multiplex immunoassays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Syphilis Immunoassay Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on syphilis immunoassay diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for syphilis immunoassay diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The syphilis immunoassay diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Analyzers; Reagents; Kits; Other Products
• 2) By Technology: Chemiluminescence Immunoassay (CLIA); Enzyme-Linked Immunosorbent Assay (ELISA); Other Technologies
• 3) By Application: Men; Women
• 4) By End-User: Hospitals; Blood Banks; Diagnostics Labs; Other End-Users
• Subsegments:
• 1) By Analyzers: Automated Analyzers; Semi-Automated Analyzers; Manual Analyzers
• 2) By Reagents: Enzyme-Linked Immunosorbent Assay Reagents; Chemiluminescent Immunoassay Reagents; Rapid Plasma Reagin Reagents; Treponemal and Non-Treponemal Reagents
• 3) By Kits: ELISA Kits; Rapid Diagnostic Test Kits; CLIA Kits; Point-Of-Care Test Kits
• 4) By Other Products: Control and Calibration Materials; Sample Collection Devices; Ancillary Testing Accessories
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Syphilis Immunoassay Diagnostics Market Characteristics

3. Syphilis Immunoassay Diagnostics Market Trends And Strategies

4. Syphilis Immunoassay Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Syphilis Immunoassay Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Syphilis Immunoassay Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Syphilis Immunoassay Diagnostics Market Growth Rate Analysis
• 5.4. Global Syphilis Immunoassay Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Syphilis Immunoassay Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Syphilis Immunoassay Diagnostics Total Addressable Market (TAM)

6. Syphilis Immunoassay Diagnostics Market Segmentation

• 6.1. Global Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analyzers
• Reagents
• Kits
• Other Products
• 6.2. Global Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemiluminescence Immunoassay (CLIA)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Other Technologies
• 6.3. Global Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Men
• Women
• 6.4. Global Syphilis Immunoassay Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Blood Banks
• Diagnostics Labs
• Other End-Users
• 6.5. Global Syphilis Immunoassay Diagnostics Market, Sub-Segmentation Of Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Analyzers
• Semi-Automated Analyzers
• Manual Analyzers
• 6.6. Global Syphilis Immunoassay Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay Reagents
• Chemiluminescent Immunoassay Reagents
• Rapid Plasma Reagin Reagents
• Treponemal and Non-Treponemal Reagents
• 6.7. Global Syphilis Immunoassay Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ELISA Kits
• Rapid Diagnostic Test Kits
• CLIA Kits
• Point-Of-Care Test Kits
• 6.8. Global Syphilis Immunoassay Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Control and Calibration Materials
• Sample Collection Devices
• Ancillary Testing Accessories

7. Syphilis Immunoassay Diagnostics Market Regional And Country Analysis

• 7.1. Global Syphilis Immunoassay Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Syphilis Immunoassay Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Syphilis Immunoassay Diagnostics Market

• 8.1. Asia-Pacific Syphilis Immunoassay Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Syphilis Immunoassay Diagnostics Market

• 9.1. China Syphilis Immunoassay Diagnostics Market Overview
• 9.2. China Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Syphilis Immunoassay Diagnostics Market

• 10.1. India Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Syphilis Immunoassay Diagnostics Market

• 11.1. Japan Syphilis Immunoassay Diagnostics Market Overview
• 11.2. Japan Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Syphilis Immunoassay Diagnostics Market

• 12.1. Australia Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Syphilis Immunoassay Diagnostics Market

• 13.1. Indonesia Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Syphilis Immunoassay Diagnostics Market

• 14.1. South Korea Syphilis Immunoassay Diagnostics Market Overview
• 14.2. South Korea Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Syphilis Immunoassay Diagnostics Market

• 15.1. Western Europe Syphilis Immunoassay Diagnostics Market Overview
• 15.2. Western Europe Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Syphilis Immunoassay Diagnostics Market

• 16.1. UK Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Syphilis Immunoassay Diagnostics Market

• 17.1. Germany Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Syphilis Immunoassay Diagnostics Market

• 18.1. France Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Syphilis Immunoassay Diagnostics Market

• 19.1. Italy Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Syphilis Immunoassay Diagnostics Market

• 20.1. Spain Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Syphilis Immunoassay Diagnostics Market

• 21.1. Eastern Europe Syphilis Immunoassay Diagnostics Market Overview
• 21.2. Eastern Europe Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Syphilis Immunoassay Diagnostics Market

• 22.1. Russia Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Syphilis Immunoassay Diagnostics Market

• 23.1. North America Syphilis Immunoassay Diagnostics Market Overview
• 23.2. North America Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Syphilis Immunoassay Diagnostics Market

• 24.1. USA Syphilis Immunoassay Diagnostics Market Overview
• 24.2. USA Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Syphilis Immunoassay Diagnostics Market

• 25.1. Canada Syphilis Immunoassay Diagnostics Market Overview
• 25.2. Canada Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Syphilis Immunoassay Diagnostics Market

• 26.1. South America Syphilis Immunoassay Diagnostics Market Overview
• 26.2. South America Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Syphilis Immunoassay Diagnostics Market

• 27.1. Brazil Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Syphilis Immunoassay Diagnostics Market

• 28.1. Middle East Syphilis Immunoassay Diagnostics Market Overview
• 28.2. Middle East Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Syphilis Immunoassay Diagnostics Market

• 29.1. Africa Syphilis Immunoassay Diagnostics Market Overview
• 29.2. Africa Syphilis Immunoassay Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Syphilis Immunoassay Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Syphilis Immunoassay Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Syphilis Immunoassay Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Syphilis Immunoassay Diagnostics Market Competitive Landscape
• 30.2. Syphilis Immunoassay Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Syphilis Immunoassay Diagnostics Market Other Major And Innovative Companies

• 31.1. bioMerieux SA
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. Meril Life Sciences Pvt. Ltd.
• 31.4. Randox Laboratories Ltd.
• 31.5. SEKISUI Diagnostics
• 31.6. Bloodworks Northwest
• 31.7. LetsGetChecked
• 31.8. Everlywell Inc.
• 31.9. ACON Laboratories Inc.
• 31.10. Trinity Biotech
• 31.11. Fujirebio
• 31.12. CTK Biotech Inc.
• 31.13. bioLytical Laboratories Inc.
• 31.14. AdvaCare Pharma
• 31.15. MyBioSource.com

32. Global Syphilis Immunoassay Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Syphilis Immunoassay Diagnostics Market

34. Recent Developments In The Syphilis Immunoassay Diagnostics Market

35. Syphilis Immunoassay Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Syphilis Immunoassay Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Syphilis Immunoassay Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Syphilis Immunoassay Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer